EpiPen Recall Expanded, EpiPen Users Please Read

Updated on Monday, April 3, 2017

Atlanta Allergy & Asthma News
Atlanta Allergy & Asthma patients who have EpiPens, please be aware the recall has expanded to include lots distributed in the U.S. The recall impacts the 0.3 mg and 0.15 mg strengths of EpiPen Auto-Injector. None of the recalled lots include the authorized generic for EpiPen Auto-Injector, which is also manufactured by Meridian Medical Technologies.

Please check your EpiPen against the lots listed in this the link below. If you have any questions or concerns, contact your Atlanta Allergy office via your patient portal or by phone.

Click here for more information.